Viehbacher to lead Sanofi-Aventis Viehbacher will replace Gerard Le Fur, who was ousted. FORMED: 2004 through a merger of Sanofi-Synthelabo and Aventis BUSINESS: Discover, develop and market medicines such as anti-clot...
Paris (ots/PRNewswire) - - Abstracts 185 and 1112 Sanofi-aventis, a world leader in diabetes care, announced results from two randomized clinical studies presented at the European Association for the Study of Diabetes...
Silicon Valley / San Jose Business Journal , a pharmaceutical company developing a transdermal delivery technology, on Monday named Gail Schulze chairperson and chief executive. Fremont-based Zosano said Don Brown was...
Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention (PCI) with the CYPHER® Sirolimus-eluting Coronary Stent was comparable to bypass surgery...
Posted on: Thursday, 4 September 2008, 06:00 CDT Research and Markets (http://www.researchandmarkets.com/research/6ec1f0/nutritional_raw_ma) has announced the addition of the "Nutritional Raw Material & Ingredient Supply...
Jan Korselt, Reuters 3.9.2008 * Zentiva seeks partner to expand in target markets * Could make big acquisition or merge within 3 yrs * Repeats full-year view of 20 pct sales rise, 15 pct EBIT By Jana Mlcochova and Jan...
Research and Markets (http://www.researchandmarkets.com/research/8c1471/the_top_10_worlds) has announced the addition of the "The Top 10 World's Leading Pharmaceutical Companies: Sanofi- The TOP 10, a unique series of...
Not even Warren Buffett was immune to the stock market’s rampant first-half gyrations, as Berkshire Hathaway Inc. (BRK.A, BRK.B) notched its worst first half in 18 years, with the shares skidding more than 16%. But only a...
STOCKS, STOCK MARKET, CNBC, CNBC.COM, STOCK BLOG, CNBC STOCK BLOG, INVESTMENT, PORTFOLIO You're never too young to pick stocks, and 21-year-old Laura Bordelon is living -- and investing -- proof. She's portfolio manager...